Study Stopped
Feasibility study - not able to recruit intended sample size in the desired period. Randomization halted, enrolled patients will be followed to 1 year follow-up
Hip Arthroscopy Versus Total Hip Arthroplasty RCT
Clinical and Cost-effectiveness of Hip Arthroscopy Versus Definitive Total Hip Arthroplasty in 40-60 Year Olds With Early Hip Osteoarthritis: A Randomized Trial
1 other identifier
interventional
42
1 country
2
Brief Summary
The aim of the proposed study is to perform a comparative pilot, randomized controlled trial of hip arthroscopy versus definitive total hip arthroplasty (THA) for the treatment of early hip osteoarthritis (Tönnis Grade 1-2) in patients between the ages of 40-60 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2020
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 12, 2019
CompletedFirst Posted
Study publicly available on registry
November 18, 2019
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedMarch 17, 2026
March 1, 2026
4.6 years
November 12, 2019
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Hip Dysfunction and Osteoarthritis Outcome Score (HOOS)
Subscales measuring Pain, Symptoms, Activity limitations daily living and Function in sport and recreation The outcome measure is transformed in a worst to best scale from 0 to 100, with 100 indicating no symptoms and 0 indicating extreme symptoms.
6 weeks, 3, 6 and 12 months
Secondary Outcomes (11)
Change in International Hip Outcome Tool [iHOT]
6 weeks, 3, 6 and 12 months
Change in Hip Outcome Score
6 weeks, 3, 6 and 12 months
Change in Modified Harris Hip Score
6 weeks, 3, 6 and 12 months
EQ-5D
6 weeks, 3, 6 and 12 months
Cost Utilization
6 weeks, 3, 6 and 12 months
- +6 more secondary outcomes
Study Arms (2)
Hip Arthroscopy
ACTIVE COMPARATORPatients in the Hip Arthroscopy group will undergo arthroscopy in the supine position under general anesthesia, with all procedures performed by two subspecialty-trained hip arthroscopists. An algorithmic surgical approach will be utilized to sequentially address pathology in the central and peripheral compartments of the hip based on both preoperative imaging findings and intraoperative findings. Emphasis will be placed on labral preservation and refixation, with osseous decompression under fluoroscopic guidance.
Total Hip Arthroplasty
ACTIVE COMPARATORPatients randomized to the Total Hip Replacement (THR) group will undergo THR via a direct anterior approach. A slightly oblique skin incision measuring approximately 8 cm will be used, starting 3 cm distally and laterally to the anterosuperior iliac spine. The intervals between tensor fascia lata (TFL) and sartorius will be developed superficially, and between rectus femoris and gluteus minimus deeper. Capsulotomy will be performed. A double osteotomy of the femoral neck will be performed to facilitate removal of the head followed by traditional preparation of the acetabulum using an offset reamer and the acetabular component will be inserted. Next, the superior capsule will be released to elevate the femur to allow access to the femoral canal, followed by standard preparation by use of an offset broach and the stem will be implanted
Interventions
Patients in the Hip Arthroscopy group will undergo arthroscopy in the supine position under general anesthesia, with all procedures performed by two subspecialty-trained hip arthroscopists. An algorithmic surgical approach will be utilized to sequentially address pathology in the central and peripheral compartments of the hip based on both preoperative imaging findings and intraoperative findings. Emphasis will be placed on labral preservation and refixation, with osseous decompression under fluoroscopic guidance.
Patients randomized to the Total Hip Replacement (THR) group will undergo THR via a direct anterior approach. A slightly oblique skin incision measuring approximately 8 cm will be used, starting 3 cm distally and laterally to the anterosuperior iliac spine. The intervals between tensor fascia lata (TFL) and sartorius will be developed superficially, and between rectus femoris and gluteus minimus deeper. Capsulotomy will be performed. A double osteotomy of the femoral neck will be performed to facilitate removal of the head followed by traditional preparation of the acetabulum using an offset reamer and the acetabular component will be inserted. Next, the superior capsule will be released to elevate the femur to allow access to the femoral canal, followed by standard preparation by use of an offset broach and the stem will be implanted
Eligibility Criteria
You may qualify if:
- Between the ages of 40-60 years at the time of surgery.
- Radiographic evidence of mild to moderate hip OA (Tönnis Gr 0 with MRI chondral wear, Tönnis Gr 1 and 2).
- Patients must have completed ≥3 months of non-operative management with ongoing symptoms.
You may not qualify if:
- Advanced OA, defined as \<2 mm joint space (Tönnis Gr 3) or those with acetabular or femoral head cysts.
- Patients who are pregnant or may become pregnant around the time of surgery.
- Prior arthroplasty of the contralateral hip.
- Current or prior hip dysplasia (defined by a lateral centre edge angle of \<20 degrees).
- Acetabular protrusio or coxa profunda, making arthroscopic access unsafe/unfeasible.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Fraser Health
New Westminster, British Columbia, V3L 0E4, Canada
Fowler Kennedy Sport Medicine Clinic and University Hospital
London, Ontario, N6A 3K7, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ryan Degen, MD, FRCSC
Fowler Kennedy Sport Medicine Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Orthopaedic Surgeon
Study Record Dates
First Submitted
November 12, 2019
First Posted
November 18, 2019
Study Start
October 1, 2020
Primary Completion
April 30, 2025
Study Completion
April 30, 2025
Last Updated
March 17, 2026
Record last verified: 2026-03